Member Sign In

You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

The company has delivered better-than-expected results in the last four quarters, recording a positive average earnings surprise of 5.59%. Notably, in the last reported quarter, the company’s earnings of $1.69 per share surpassed the Zacks Consensus Estimate by 6.96%. Estimates for the to-be-reported quarter are pegged at $1.61, depicting a 7.33% year-over-year growth.

In the last year, the company’s shares have dipped 1.5%, against the industry’s gain of 2.1%.

Let us see how things are shaping up for the company prior to this announcement.

Earnings Whispers

Our proven model does not conclusively show that International Flavors & Fragrances is likely to beat on earnings this quarter. This is because a stock needs to have both a positive Earnings ESP and a favorable Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. But that is not the case here as you will see below.

Zacks ESP: International Flavors & Fragrances has an Earnings ESP of -0.21%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

International Flavors & Fragrances’ expectation for the full year gives a glimpse of the factors that are likely to influence the quarterly results. The company anticipates gaining from acquired businesses as well as its multi-year productivity program, enabling it to control costs, make strategic investments and expand businesses globally. Moreover, the company's exhaustive research and development wing focuses on the development of new and innovative compounds. Veraspice — a fragrance ingredient; Tastepoint — a new company to serve middle-market customers; and Re-Imagine — programs that enable capture of unaddressed opportunities in the food and beverage industry as well as assist the company in its innovation initiatives, will prove beneficial in the quarter.

The Zacks Consensus Estimate for total revenues is pegged at $899 million, projecting year-over-year growth of 6.7%.

For the Flavors segment, continued growth in a number of consumer food companies, as well as the need for more transparency in consumer products, has created opportunities for the company. Demand for flavors is strong from Savory, Sweet and Dairy categories. The segment will gain from the PowderPure buyout and the creation of Tastepoint — a new company to serve middle-market customers. Both the buyout and the company formation were accomplished in 2017.

The Flavors segment’s Zacks Consensus Estimate for revenues is pegged at $443 million for the second quarter of 2018. This projection reflects year-over-year growth of 7% for the segment. It is expected to report an operating profit of $107 million in the to-be-reported quarter, up 7% from the prior year reported figure. This will likely be driven by volume growth and benefits from productivity initiatives.

In addition to growing population and rising product demand, the company’s Fragrances segment will gain from new business wins and more businesses from existing customers. Demand for Fragrance Compounds and Ingredients remain strong. Further, the acquisition of Fragrance Resources in 2017 and the creation of new fragrance ingredient called Veraspice will act as growth drivers.

The Fragrances segment’s Zacks Consensus Estimate for revenues is pegged at $459 million for the second quarter of 2018. This projection is above $$429 million recorded in the year-ago quarter. The segment’s operating profit is expected to rise 4% year over year to $88 million.

Meanwhile, rise in raw material costs as well as higher selling, general and administrative expenses will constrain margins. Moreover, a high-debt level and unfavorable movements in foreign currencies are causes of concern.

The Zacks Consensus Estimate for earnings is pegged at $1.61 for the quarter, reflecting year-over-year growth of 7.33%.

Stocks to Consider

Here are some stocks you may want to consider, as according to our model these have the right combination of elements to post an earnings beat this quarter.

Trecora Resources (TREC - Free Report) has an Earnings ESP of +13.64% and a Zacks Rank #3. Its shares have gained 16% over the past year.

Marrone Bio Innovations, Inc. has an Earnings ESP of +25.00% and a Zacks Rank #3. Its shares have appreciated 104% over the past year.

Today's Stocks from Zacks' Hottest Strategies

It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

Zacks Mobile App

Zacks Research is Reported On:

At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +25.26% per year. These returns cover a period from January 1, 1988 through December 3, 2018. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations.

Visit performance for information about the performance numbers displayed above.

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service.